Carousel Studio

Repurpose X Threads into LinkedIn & Instagram Carousels

Canvas & Ratio

Choose your destination platform format


Layout Template

Choose a content structure for your slides


Preset Themes


Typography & Sizing

Title Font Size36px
Body Font Size18px
Header & Footer Size12px

Brand Kit Customization

AGENCY

Configure brand assets for headers & footers

MULTI-PROFILES (AGENCY)
AGENCY
SAVE PRESETS (AGENCY)

Outro Slide CTA

Customize your closing call-to-action slide

#1
#2
#3

Background Pattern

Source Content

Build Your Carousel

Drag and drop any post card below onto a slide, or use the quick buttons to insert content/images instantly!

Drag Post #1
Brad Setser
@Brad_Setser

It isn't exactly a secret that I view the US pharmaceutical trade deficit as a bit of a Rorschach test -- it tests whether folks form their opinion on trade issues by listening to interest groups, the President (now) or by looking at the actual trade data 1/

Apply Image
Drag Post #2
Brad Setser
@Brad_Setser

It is also a way to illustrate that trade deficits don't simply stem from tariffs (or non-tariff barriers). Tariffs on on pharmaceuticals are zero. & I haven't heard any complaints about non-tariff barriers in Ireland, Singapore, Switzerland and Belgium (IP box) either. 2/

Apply Image
Drag Post #3
Brad Setser
@Brad_Setser

If you look at USTR's report on foreign trade barriers (the one Trump held up on Wednesday) you will find lots of complaints about national health insurance systems negotiating down drug prices -- and no complaints about "pro-business" tax centers like Ireland and Sing 3/

Drag Post #4
Brad Setser
@Brad_Setser

The US trade deficit in pharmaceuticals is: a) now big, about half a point of GDP b) very clearly a consequence of the TCJA (the deficit went from $60b to $160b since it passed) & c) not a function of tariffs or NTBs in the sources of deficit -- 4/

Apply Image
Drag Post #5
Brad Setser
@Brad_Setser

The chart of the deficit looks like the chart of imports from low tax jurisdictions for a reason - -and what's more, the pharma deficit is exploding right now (& for reasons that go well beyond front running, the import surge started early last year) 5/

Apply Image
Drag Post #6
Brad Setser
@Brad_Setser

If the Trump administration was serious about fixing the pharmaceutical deficit, it would fix the pro-offshoring provisions of the TCJA -- not tariff Lesotho and Sri Lanka! 6/

Drag Post #7
Brad Setser
@Brad_Setser

The administration also has some problems with understanding magnitudes. The pharma deficit is $160b -- and imports are surging. That is real money -- 7/

Apply Image
Drag Post #8
Brad Setser
@Brad_Setser

The damage to the US economy from Canadian dairy protectionism and different standards for butchering poultry across the Atlantic (something Lutnick keeps mentioning) are in the hundreds of millions of dollar range, may be $1 b if done accurately ... 8/

Drag Post #9
Brad Setser
@Brad_Setser

Which gets to my final point: the tariff cure (as structured last Wed) for the relatively tiny problems that the administration has identified (poultry butchering standards) is out of proportion with any reasonable sense of the harm. Hence the justified market reaction. 10/10